202 related articles for article (PubMed ID: 32627089)
81. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
82. [CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospective study].
Magomedova AU; Misyurina AE; Mangasarova JK; Gorenkova LG; Margolin OV; Fastova EA; Kravchenko SK
Ter Arkh; 2019 Jul; 91(7):35-40. PubMed ID: 32598734
[TBL] [Abstract][Full Text] [Related]
83. Cytological diagnosis of vitreoretinal lymphomas: A case series.
Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
[TBL] [Abstract][Full Text] [Related]
84. Diffuse large B-cell lymphoma involving the central nervous system.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Int J Surg Pathol; 2011 Feb; 19(1):44-50. PubMed ID: 21087986
[TBL] [Abstract][Full Text] [Related]
85. Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma.
Fiskvik I; Beiske K; Delabie J; Yri O; Spetalen S; Karjalainen-Lindsberg ML; Leppä S; Liestøl K; Smeland EB; Holte H
Leuk Lymphoma; 2015 Jun; 56(6):1742-9. PubMed ID: 25284491
[TBL] [Abstract][Full Text] [Related]
86. [Primary central nervous system lymphoma: pathogenesis and histomorphology].
Méhes G
Magy Onkol; 2017 Mar; 61(1):81-87. PubMed ID: 28273192
[TBL] [Abstract][Full Text] [Related]
87. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
88. Gene expression and angiotropism in primary CNS lymphoma.
Rubenstein JL; Fridlyand J; Shen A; Aldape K; Ginzinger D; Batchelor T; Treseler P; Berger M; McDermott M; Prados M; Karch J; Okada C; Hyun W; Parikh S; Haqq C; Shuman M
Blood; 2006 May; 107(9):3716-23. PubMed ID: 16418334
[TBL] [Abstract][Full Text] [Related]
89. Primary lymphoma of the central nervous system: just DLBCL or not?
Montesinos-Rongen M; Siebert R; Deckert M
Blood; 2009 Jan; 113(1):7-10. PubMed ID: 18802010
[No Abstract] [Full Text] [Related]
90. High frequency of inactivating tetraspanin
Elfrink S; de Winde CM; van den Brand M; Berendsen M; Roemer MGM; Arnold F; Janssen L; van der Schaaf A; Jansen E; Groenen PJTA; Eijkelenboom A; Stevens W; Hess CJ; van Krieken JH; Vermaat JSP; Cleven AHG; de Groen RAL; Neviani V; de Jong D; van Deventer S; Scheijen B; van Spriel AB
Blood; 2019 Sep; 134(12):946-950. PubMed ID: 31366619
[TBL] [Abstract][Full Text] [Related]
91. Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome.
Muñiz C; Martín-Martín L; López A; Sánchez-González B; Salar A; Almeida J; Sancho JM; Ribera JM; Heras C; Peñalver FJ; Gómez M; González-Barca E; Alonso N; Navarro B; Olave T; Sala F; Conde E; Márquez JA; Cabezudo E; Cladera A; García-Malo M; Caballero MD; Orfao A;
Blood; 2014 Mar; 123(12):1864-9. PubMed ID: 24501214
[TBL] [Abstract][Full Text] [Related]
92. Effect of P53 expression on double-expressor lymphoma and characteristics of DLBCL co-expressing P53 and MYC: Clinical, pathological, and biological insights.
Chen YZ; Bo JL; Hou SL
Asian J Surg; 2024 Jun; 47(6):2852-2855. PubMed ID: 38408882
[No Abstract] [Full Text] [Related]
93. Pathway analysis of primary central nervous system lymphoma.
Tun HW; Personett D; Baskerville KA; Menke DM; Jaeckle KA; Kreinest P; Edenfield B; Zubair AC; O'Neill BP; Lai WR; Park PJ; McKinney M
Blood; 2008 Mar; 111(6):3200-10. PubMed ID: 18184868
[TBL] [Abstract][Full Text] [Related]
94. Primary central nervous system lymphomas with massive intratumoral hemorrhage: Clinical, radiological, pathological, and molecular features of six cases.
Yamada S; Muto J; Iba S; Shiogama K; Tsuyuki Y; Satou A; Ohba S; Murayama K; Sugita Y; Nakamura S; Yokoo H; Tomita A; Hirose Y; Tsukamoto T; Abe M
Neuropathology; 2021 Oct; 41(5):335-348. PubMed ID: 34254378
[TBL] [Abstract][Full Text] [Related]
95. Lymphomas mimicking neuroinflammatory diseases - A diagnostic conundrum worth revisiting.
Raza SA; Raza M; Dai M; Husan A; Cotelingam J; AlHussein H
J Neuroimmunol; 2022 Nov; 372():577970. PubMed ID: 36137305
[TBL] [Abstract][Full Text] [Related]
96. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.
Lauw MIS; Lucas CG; Ohgami RS; Wen KW
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322508
[TBL] [Abstract][Full Text] [Related]
97. Selective central nervous system tropism of primary central nervous system lymphoma.
Jiang L; Marlow LA; Cooper SJ; Roemeling CV; Menke DM; Copland JA; Tun HW
Int J Clin Exp Pathol; 2010 Oct; 3(8):763-7. PubMed ID: 21151389
[TBL] [Abstract][Full Text] [Related]
98. Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones.
Patel BM; Moesch J; Karunamurthy A; Puleio DV; Drappatz J; Akilov OE; Kazlouskaya V
J Cutan Pathol; 2022 Jan; 49(1):90-94. PubMed ID: 34498750
[TBL] [Abstract][Full Text] [Related]
99. Rare central nervous system lymphomas.
Kaji FA; Martinez-Calle N; Sovani V; Fox CP
Br J Haematol; 2022 Jun; 197(6):662-678. PubMed ID: 35292959
[TBL] [Abstract][Full Text] [Related]
100. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development.
McCann KJ; Ashton-Key M; Smith K; Stevenson FK; Ottensmeier CH
Blood; 2009 May; 113(19):4677-80. PubMed ID: 19096008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
